SPRO

Spero Therapeutics Inc

Jun 03 • 04:00PM ET

2.80

-0.03 -1.06 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN CNTB GALT IMUX KZIA VRCA MOLN HURA ORMP PLX

| Held by: VTI VXF DFMC DFAS QQQS AVSC PRFZ DCOR DFAT DFAC

Scroll to Statements

Index	-	P/E	11.49	EPS (ttm)	0.24	Insider Own	25.86%	Shs Outstand	57.89M	Perf Week	-4.44%
Market Cap	162.12M	Forward P/E	3.68	EPS next Y	0.76	Insider Trans	-1.30%	Shs Float	42.93M	Perf Month	12.00%
Enterprise Value	108.46M	PEG	-	EPS next Q	-	Inst Own	14.47%	Short Float	3.84%	Perf Quarter	22.27%
Income	15.23M	P/S	2.96	EPS this Y	346.67%	Inst Trans	-1.55%	Short Ratio	3.16	Perf Half Y	23.35%
Sales	54.77M	P/B	3.06	EPS next Y	13.43%	ROA	22.28%	Short Interest	1.65M	Perf YTD	20.17%
Book/sh	0.91	P/C	2.89	EPS next 5Y	-	ROE	35.12%	52W High	3.22 -13.04%	Perf Year	6.06%
Cash/sh	0.97	P/FCF	22.39	EPS past 3/5Y	- -	ROIC	28.51%	52W Low	1.80 55.56%	Perf 3Y	53.85%
Dividend Est.	-	EV/EBITDA	13.98	Sales past 3/5Y	7.06% 197.00%	Gross Margin	-	Volatility	4.19% 5.93%	Perf 5Y	-80.85%
Dividend TTM	-	EV/Sales	1.98	EPS Y/Y TTM	121.50%	Oper. Margin	14.16%	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.50	Sales Y/Y TTM	93.50%	Profit Margin	27.82%	RSI (14)	55.95	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.50	EPS Q/Q	49.76%	SMA20	3.88%	Beta	1.46	Target Price	4.00
Payout	0.00%	Debt/Eq	0.05	Sales Q/Q	-94.95%	SMA50	6.26%	Rel Volume	1.51	Prev Close	2.83
Employees	25	LT Debt/Eq	0.01	Earnings	May 13 AMC	SMA200	18.74%	Avg Volume	520.53K	Price	2.80
IPO	Nov 02, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	775,516	Change	-1.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)